58S mesoporous bioactive glass as a structural enhancer in α-TCP-based bone cements: gains in strength, challenges in bioactivity
Source abstract
Abstract
• Adding mesoporous bioactive glass extends setting time and strengthens bone cements. • Higher bioactive glass content reduces total porosity and increases closed porosity. • Plain cement induces stronger early osteogenic response due to higher open porosity. • Osteogenic markers trended higher in MBG groups without significant difference. Calcium phosphate bone cements (CPCs) are promising injectable bone substitutes but are limited by insufficient mechanical strength, prolonged setting time, and inadequate degradation profile. This study investigates the incorporation of mesoporous bioactive glass (58S MBG) into α-tricalcium phosphate (α-TCP)-based CPCs to enhance their physicochemical and biological performance. Composites containing 0–15 wt% MBG were fabricated and evaluated across multiple powder-to-liquid ratios. MBG addition extended final setting time from 9 to 42 min and increased compressive strength over threefold (from 3.39 to 10.40 MPa). Total porosity decreased (78 % to 61 %) while closed porosity increased, improving structural integrity. BG0 (0 %), BG5 (5 %), and BG9 (9 %) were selected for further in vitro testing with human mesenchymal stem cells. While BG0 supported early alkaline phosphatase (ALP) activity, BG5 and BG9 showed prolonged ALP response and upregulation of key osteogenic markers (ALP, COL1, RUNX2, SP7). Osteocalcin expression remained low across groups, indicating limited late-stage differentiation within the study period. The results demonstrate that MBG-modified CPCs offer enhanced mechanical performance and support osteogenic activity in vitro . These findings underscore the potential of MBG integration for optimizing CPC formulations aimed at minimally invasive bone regeneration applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. The clinical use of bone graft substitutes in orthopedic surgery in Germany—A 10-years survey from 2008 to 2018 of 1,090,167 surgical interventions10.1002/jbm.b.34911 ↗
2. M.P. Ferraz, Bone Grafts in Dental Medicine: An Overview of Autografts, Allografts and Synthetic Materials., Mater. (Basel, Switzerland). 16 (2023). https://doi.org/10.3390/ma16114117.10.3390/ma16114117 ↗
3. Limitations of autograft and allograft: new synthetic solutions
4. Bone graft substitutes currently available in orthopaedic practice10.1302/0301-620X.95B5.30286 ↗
5. Bone grafts and substitutes in dentistry: a review of current trends and developments10.3390/molecules26103007 ↗
6. Calcium phosphate cements for bone substitution: chemistry, handling and mechanical properties10.1016/j.actbio.2013.11.001 ↗
7. Limitations and modifications in the clinical application of calcium sulfate10.3389/fsurg.2024.1278421 ↗
8. Injectable bone cements: what benefits the combination of calcium phosphates and bioactive glasses could bring?
9. Calcium phosphate cements: Optimization toward biodegradability10.1016/j.actbio.2020.10.013 ↗
10. Personalized bioceramic grafts for craniomaxillofacial bone regeneration10.1038/s41368-024-00327-7 ↗
11. Composites consisting of calcium phosphate cements and mesoporous bioactive glasses as a 3D plottable drug delivery system10.1016/j.actbio.2022.01.034 ↗
12. Design strategies and biomimetic approaches for calcium phosphate scaffolds in bone tissue regeneration10.3390/biomimetics7030112 ↗
13. Mesoporous bioactive glass-incorporated injectable strontium-containing calcium phosphate cement enhanced osteoconductivity in a critical-sized metaphyseal defect in osteoporotic rats10.3390/bioengineering10101203 ↗
14. Optimizing α-tricalcium phosphate bone cement composite formulations: the critical role of bioactive glass particle size10.1016/j.matdes.2024.113463 ↗
15. A.C.M. Renno, M.R. Nejadnik, F.C.J. Van De Watering, M.C. Crovace, E.D. Zanotto, J.P.M. Hoefnagels, J.G.C. Wolke, J.A. Jansen, J.J.J.P. Van Den Beucken, Incorporation of bioactive glass in calcium phosphate cement: Material characterization and in vitro degradation, J. Biomed. Mater. Res. - Part A. 101 A (2013) 2365–2373. https://doi.org/10.1002/jbm.a.34531.10.1002/jbm.a.34531 ↗
16. Bioactive glass incorporation in calcium phosphate cement-based injectable bone substitute for improved in vitro biocompatibility and in vivo bone regeneration10.1177/0885328213478256 ↗
17. A Novel injectable calcium phosphate cement-bioactive glass composite for bone regeneration
18. Of the in vivo behavior of calcium phosphate cements and glasses as bone substitutes10.1016/j.actbio.2008.04.023 ↗
19. Novel bioactive nanocomposite cement formulations with potential properties: incorporation of the nanoparticle form of mesoporous bioactive glass into calcium phosphate cements10.1039/C4TB01634C ↗
20. Calcium phosphate bone cement/mesoporous bioactive glass composites for controlled growth factor delivery10.1039/C6BM00903D ↗
21. Novel bioactive glass based injectable bone cement with improved osteoinductivity and its in vivo evaluation
22. Treatment of critical bone defects using calcium phosphate cement and mesoporous bioactive glass providing spatiotemporal drug delivery
23. Biological properties of calcium phosphate bioactive glass composite bone substitutes: current experimental evidence10.3390/ijms20020305 ↗
24. Octacalcium phosphate phase forming cements as an injectable bone substitute materials: preparation and in vitro structural study10.1016/j.bioadv.2023.213731 ↗
25. Ammonium hydrogen carbonate provided viscous slurry foaming-a novel technology for the preparation of porous ceramics10.1016/j.jeurceramsoc.2013.06.010 ↗
26. How useful is SBF in predicting in vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
27. Profex: a graphical user interface for the Rietveld refinement program BGMN10.1107/S1600576715014685 ↗
28. Preparation, in vitro bioactivity and drug release property of well-ordered mesoporous 58S bioactive glass10.1016/j.jnoncrysol.2006.10.084 ↗
29. Mesoporous bioactive glass-enhanced MSC-derived exosomes promote bone regeneration and immunomodulation in vitro and in vivo
30. The reactivity of α-tricalcium phosphate powders is affected by minute amounts of β-calcium pyrophosphate and by the synthesis temperature
31. Rapid-setting, mesoporous, bioactive glass cements that induce accelerated in vitro apatite formation10.1002/adma.200502292 ↗
32. Bioactive glass and glass-ceramic scaffolds for bone tissue engineering10.3390/ma3073867 ↗
33. Modifications of a calcium phosphate cement with biomolecules-Influence on nanostructure, material, and biological properties10.1002/jbm.a.32920 ↗
34. Effects of the method of apatite seed crystals addition on setting reaction of α-tricalcium phosphate based apatite cement10.1007/s10856-015-5570-8 ↗
35. Octacalcium phosphate: innovative vehicle for the local biologically active substance delivery in bone regeneration10.1016/j.actbio.2021.08.021 ↗
36. Hydroxyapatite formation from octacalcium phosphate and its related compounds: a discussion of the transformation mechanism10.1246/bcsj.20200031 ↗
37. Biomimetic systems for hydroxyapatite mineralization inspired by bone and enamel10.1021/cr8004422 ↗
38. Bone formation enhanced by implanted octacalcium phosphate involving conversion into Ca-deficient hydroxyapatite10.1016/j.biomaterials.2005.12.004 ↗
39. α-TCP-based calcium phosphate cements: a critical review10.1016/j.actbio.2022.08.040 ↗
40. The biocompatibility of porous vs non-porous bone cements: a new methodological approach
41. Long-term in vitro degradation of a high-strength brushite cement in water, PBS, and Serum SOLution10.1155/2015/575079 ↗
42. Mesoporous bioactive glasses for regenerative medicine
43. Tailoring of bioactive glass and glass-ceramics properties for in vitro and in vivo response optimization: a review10.1039/D3BM01574B ↗
44. An injectable pH neutral bioactive glass-based bone cement with suitable bone regeneration ability
45. The interplay of collagen/bioactive glass nanoparticle coatings and electrical stimulation regimes distinctly enhanced osteogenic differentiation of human mesenchymal stem cells10.1016/j.actbio.2022.06.045 ↗
46. Regulation of human osteoblast-to-osteocyte differentiation by direct-write 3D microperiodic hydroxyapatite scaffolds10.1021/acsomega.8b03272 ↗
47. Establishing a deeper understanding of the osteogenic differentiation of monolayer cultured human pluripotent stem cells using novel and detailed analyses10.1186/s13287-020-02085-9 ↗
48. Osteocalcin mediates biomineralization during osteogenic maturation in human mesenchymal stromal cells10.3390/ijms18010159 ↗